• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by GX Acquisition Corp. (Amendment)

    7/15/21 1:21:23 PM ET
    $GXGX
    Business Services
    Finance
    Get the next $GXGX alert in real time by email
    SC 13G/A 1 lf_sc13gz.htm SCHEDULE 13G/A - AMENDMENT Schedule 13G/A - Amendment

     

     

    OMB APPROVAL

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    OMB Number:3235-0145 

    Expires:Febuary 28, 2009 

    Estimated average burden
    hours per response ....10.4

     

     

    SCHEDULE 13G

    Under the Securities and Exchange Act of 1934

    (Amendment No.       1          )*

     

    GX Acquisition Corp.

    (Name of Issuer)

     

    Class A Common Stock, par value $ 0.0001

    (Title of Class of Securities)

     

    36251A107

    (CUSIP Number)

     

     

    July 15, 2021

    (Date of Event which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    o  Rule 13d-1(b)

    ý  Rule 13d-1(c)

    o  Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    1


     

    CUSIP No.   36251A107

    1.Names of Reporting Persons. 

    I.R.S. Identification Nos. of above persons (entities only). 

    Feis Equities LLC 

    2.Check the Appropriate Box if a Member of a Group 

    (a)o 

    (b)o 

    3.SEC Use Only 

    4.Citizenship or Place of OrganizationState of Illinois 

    Number of Shares Beneficially Owned by Each Reporting Person With

    5.Sole Voting Power0 

    6.Shared Voting Power0 

    7.Sole Dispositive Power0 

    8.Shared Dispositive Power    0 

    9.Aggregate Amount Beneficially Owned by Each Reporting Person 

    0 

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)      o 

    11.Percent of Class Represented by Amount in Row (9) 

    0% 

    12.Type of Reporting Person (See Instructions) 

    OO-Limited Liability Company 


    2


     

    CUSIP No.   36251A107

    1.Names of Reporting Persons. 

    I.R.S. Identification Nos. of above persons (entities only). 

    Lawrence M. Feis 

    2.Check the Appropriate Box if a Member of a Group 

    (a)o 

    (b)o 

    3.SEC Use Only 

    4.Citizenship or Place of OrganizationU.S.A. 

    Number of Shares Beneficially Owned by Each Reporting Person With

    5.Sole Voting Power0 

    6.Shared Voting Power0 

    7.Sole Dispositive Power0 

    8.Shared Dispositive Power    0 

    9.Aggregate Amount Beneficially Owned by Each Reporting Person 

    0 

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)      o 

    11.Percent of Class Represented by Amount in Row (9)  

    0% 

    12.Type of Reporting Person (See Instructions) 

    IN 


    3


     

    Item 1.

    The name and address of the principal executive offices of the Issuer are:

    GX Acquisition Corp.

    1325 Avenue of the Americas

    25th Floor

    New York, NY  10019

    Item 2.

    This statement on Schedule 13G is being filed by:

    (a) Name of Person Filing 

     

    (i)Feis Equities LLC 

    (ii)Lawrence M. Feis 

     

     

     

     

     

    (b)Address: 

    The address of the business office of each of the Reporting Persons is:

     

    20 North Wacker Drive

    Suite 2115

    Chicago, Illinois  60606

     

     

     

     

     

    (c)Citizenship/Place: 

    Citizenship is set forth in Row 4 of the cover page for each Reporting Person hereto and is incorporated hereto by reference for each Reporting Person.

     

    (d)Title of Class of Securities: 

    Class A common stock, par value $ 0.0001 (the “Shares”)

     

    (e)CUSIP Number: 

    36251A107

     

     

     


    4


    Item 3.  If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

    (a)oBroker or dealer registered under section 15 of the Act (15 U.S.C. 78o). 

    (b)oBank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). 

    (c)oInsurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). 

    (d)oInvestment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). 

    (e)oAn investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); 

    (f)oAn employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); 

    (g)oA parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); 

    (h)oA savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); 

    (i)oA church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); 

    (j)oGroup, in accordance with §240.13d-1(b)(1)(ii)(J). 

    Item 4.  Ownership

     

    The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover page for each Reporting Person and incorporated by reference herein.

     

    The percentage set forth in row 11 of the cover page for each Reporting Person is based on 12,580,004 Shares outstanding as of May 24, 2021, which is calculated by subtracting the 16,169,996 shares redeemed as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, from the 28,750,000 shares reported on the cover page of the same document, filed with the Securities and Exchange Commission on May 24, 2021.


    5


    Item 5.  Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ý

    Item 6.  Ownership of More than Five Percent on Behalf of Another Person

    Not applicable.

    Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

    Not applicable.

    Item 8.  Identification and Classification of Members of the Group

    Not applicable.

    Item 9.  Notice of Dissolution of Group

    Not applicable.

    Item 10.  Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    6


     

    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date:July 15, 2021 

     

     

     

     

    Date:July 15, 2021 

     

    FEIS EQUITIES LLC

    By:/s/ Lawrence M. Feis 

                Managing Member LLC

     

     

    LAWRENCE M. FEIS

    By:/s/ Lawrence M. Feis 

     


    7


     

     

    EXHIBIT INDEX

     

    Ex.

     

    Page No.

     

     

     

    A

    Joint Filing Agreement

    9


    8


     

    JOINT FILING AGREEMENT

     

    The undersigned hereby agree that the statement on Schedule 13G with respect to the Class A common stock of GX Acquisition Corporation dated as of July 15, 2021 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

     

    FEIS EQUITIES LLC 

    By:/s/ Lawrence M. Feis 

    Managing Member LLC 

     

     

    LAWRENCE M. FEIS 

    By:/s/ Lawrence M. Feis 

     

    Date:  July 15, 2021


    9

    Get the next $GXGX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GXGX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GXGX
    SEC Filings

    View All

    SEC Form S-8 filed by GX Acquisition Corp.

    S-8 - Celularity Inc (0001752828) (Filer)

    10/4/21 5:05:24 PM ET
    $GXGX
    Business Services
    Finance

    SEC Form 424B3 filed by GX Acquisition Corp.

    424B3 - Celularity Inc (0001752828) (Filer)

    9/17/21 8:37:37 AM ET
    $GXGX
    Business Services
    Finance

    SEC Form 8-K filed by GX Acquisition Corp.

    8-K - Celularity Inc (0001752828) (Filer)

    9/15/21 4:49:33 PM ET
    $GXGX
    Business Services
    Finance

    $GXGX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on GX Acquisition Corp with a new price target

    BTIG Research initiated coverage of GX Acquisition Corp with a rating of Buy and set a new price target of $16.00

    3/26/21 7:12:09 AM ET
    $GXGX
    Business Services
    Finance

    $GXGX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GX Acquisition Corp. Announces Shareholder Approval of Extension Proposal

    NEW YORK, May 14, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ:GXGX), a publicly-traded special purpose acquisition company, announced today that its stockholders have voted to approve an amendment to GX's amended and restated certificate of incorporation to extend the date by which GX must effectuate its initial business combination  from May 23, 2021 to July 31, 2021. As previously disclosed, on January 8, 2021, GX entered into a Merger Agreement and Plan of Reorganization (the "Merger Agreement") with Celularity Inc. ("Celularity"), Alpha First Merger Sub, Inc. and Alpha Second Merger Sub, LLC. Upon the terms and subject to the conditions of the Merger Agreement, Celularity wi

    5/14/21 4:45:00 PM ET
    $GXGX
    Business Services
    Finance

    GX Acquisition Corp. Announces Additional Contributions to Trust Account

    NEW YORK, May 10, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ:GXGX), a publicly-traded special purpose acquisition company, today reaffirmed its intention to support the proposal to amend GX's amended and restated certificate of incorporation to extend the date by which GX must complete its initial business combination from May 23, 2021 to July 31, 2021 (the "Extension" and such later date, the "Extended Date"). This proposal will be voted on by stockholders at the upcoming special meeting of stockholders on May 14, 2021. The Extension will allow GX until the Extended Date to complete its initial business combination. In order to support this proposal, GX has agreed that, if the

    5/10/21 7:30:00 AM ET
    $GXGX
    Business Services
    Finance

    Celularity Enters into Multi-Year Strategic Partnership with Palantir Technologies

    Celularity to leverage Palantir's next generation software and computational capabilities with their deep cellular data set to accelerate research and development activities Partnership includes equity investment by Palantir in Celularity Investment, combined with previously announced PIPE investment, brings over$100 million in new funding to Celularity FLORHAM PARK, N.J., May 05, 2021 (GLOBE NEWSWIRE) -- Celularity Inc. ("Celularity"), a clinical-stage biotechnology company leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies derived from the postpartum human placenta, and Palantir Technologies Inc. (NYSE:PLTR), a software company t

    5/5/21 8:00:00 AM ET
    $PLTR
    $GXGX
    Computer Software: Prepackaged Software
    Technology
    Business Services
    Finance

    $GXGX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Pecora Andrew L

    4 - Celularity Inc (0001752828) (Issuer)

    9/17/21 2:48:53 PM ET
    $GXGX
    Business Services
    Finance

    SEC Form 3 filed by new insider Pecora Andrew L

    3 - Celularity Inc (0001752828) (Issuer)

    9/17/21 2:44:19 PM ET
    $GXGX
    Business Services
    Finance

    SEC Form 4 filed by Mirakhur Beloo

    4 - Celularity Inc (0001752828) (Issuer)

    9/15/21 6:50:54 PM ET
    $GXGX
    Business Services
    Finance

    $GXGX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by GX Acquisition Corp.

    SC 13G - Celularity Inc (0001752828) (Subject)

    7/26/21 5:19:50 PM ET
    $GXGX
    Business Services
    Finance

    SEC Form SC 13D filed by GX Acquisition Corp.

    SC 13D - Celularity Inc (0001752828) (Subject)

    7/26/21 5:16:55 PM ET
    $GXGX
    Business Services
    Finance

    SEC Form SC 13G filed by GX Acquisition Corp.

    SC 13G - Celularity Inc (0001752828) (Subject)

    7/26/21 5:10:46 PM ET
    $GXGX
    Business Services
    Finance